TrialJournal of cachexia, sarcopenia and muscle2018

LY2495655, an antimyostatin antibody, in pancreatic cancer: a randomized, phase 2 trial.

Talia Golan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.